Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02032823 |
|---|---|
| Brief Title: | Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA) |
| First Submitted : | January 3, 2014 |
| First Submitted that Met QC Criteria : | January 9, 2014 |
| First Posted : | January 10, 2014 (Estimate) |
| Results First Submitted : | September 24, 2021 |
| Results First Submitted that Met QC Criteria : | November 9, 2021 |
| Results First Posted : | December 8, 2021 |
| Certification/Extension First Submitted : | March 5, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | March 5, 2021 |
| Certification/Extension First Posted : | March 9, 2021 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |